SPIN2B

Spindlin-2B · Q9BPZ2 · SPIN2B on Sugi Atlas →

77 patent compounds predicted against SPIN2B, 59 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL29369030 SCHEMBL29369030 1.00 1/20
SCHEMBL19385205 SCHEMBL19385205 0.58 1/20
SCHEMBL29937017 SCHEMBL29937017 0.58 1/20
SCHEMBL2953260 SCHEMBL2953260 0.56 1/20
SCHEMBL28894304 SCHEMBL28894304 0.55 1/20
SCHEMBL19385373 SCHEMBL19385373 0.55 1/20
SCHEMBL1089104 SCHEMBL1089104 0.55 1/20
SCHEMBL1089641 SCHEMBL1089641 0.54 1/20
SCHEMBL1089644 SCHEMBL1089644 0.54 1/20
SCHEMBL1090089 SCHEMBL1090089 0.54 1/20
SCHEMBL19385129 SCHEMBL19385129 0.53 1/20
SCHEMBL25244226 SCHEMBL25244226 0.53 1/20
SCHEMBL28894334 SCHEMBL28894334 0.53 1/20
SCHEMBL19385236 SCHEMBL19385236 0.52 1/20
SCHEMBL19385261 SCHEMBL19385261 0.52 1/20
SCHEMBL19405236 SCHEMBL19405236 0.52 1/20
SCHEMBL25202485 SCHEMBL25202485 0.52 1/20
SCHEMBL19385009 SCHEMBL19385009 0.52 1/20
SCHEMBL23015382 SCHEMBL23015382 0.51 1/20
SCHEMBL19385024 SCHEMBL19385024 0.51 1/20

Clinical trials — most relevant to SPIN2B by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Valproate and Levocarnitine in Children With Spinal Muscular Atrophy PHASE3UNKNOWN
Study to Evaluate Sodium Phenylbutyrate in Pre-symptomatic Infants With Spinal Muscular Atrophy PHASE1/PHASE2COMPLETED
Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker Analysis PHASE2ACTIVE_NOT_RECRUITING
PHOX2B PC-CAR T Cells for Relapsed Neuroblastoma PHASE1RECRUITING
Hemolysis in Patients With Hereditary Spherocytosis (HS) nanUNKNOWN
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Consequences of Mutations in the SPG7 Gene at the Heterozygous State nanCOMPLETED
Comparison of Erector Spina Plane Block and Thoracic Paravertebral Block for Analgesia After Thoracotomy nanCOMPLETED
Predictive Progressive Factors of Adolescent Idiopathic Scoliosis nanCOMPLETED
Analysis of Post-Translational Modifications of a Critical Protein Implicated in Amyotrophic Lateral Sclerosis nanCOMPLETED
A Study of the Safety and Preliminary Efficacy of NKG001 in Pediatric Patients With Type 1 or Type 2 Spinal Muscular Atrophy nanACTIVE_NOT_RECRUITING
Implementation of Molecular Diagnostic Pathways nanUNKNOWN
GenoMed4ALL: Improving SCD Classification and Prognosis by AI nanUNKNOWN
Genetic Newborn Screening for Cystinosis and Spinal Muscular Atrophy nanCOMPLETED
GCB-001 in Treatment of Patients With Type II (SMA) Spinal Muscular Atrophy nanENROLLING_BY_INVITATION
Evaluation of Therapeutic Response in Spinal Muscular Atrophy Using Multispectral Optoacoustic Tomography (MSOT) and Magnetic Resonance Imaging (MRI) nanUNKNOWN
Adrenal& Bone Complications in Paediatric Patients Living With Spinal Muscular Atrophy (SMA) nanNOT_YET_RECRUITING
Endocrine Disruptors and Life STILe in Breast Cancer Development nanUNKNOWN
Study of Synapsis and Recombination in Male Meiosis and the Implications in Infertility nanCOMPLETED
Biomarker Research in Inherited Movement Disorders nanRECRUITING
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development nanCOMPLETED
Genetic Investigation of Solid Tumors Cohort nanCOMPLETED
Phenotypes, Biomarkers and Pathophysiology in Spastic Ataxias nanUNKNOWN
Differential Study of Muscle Transcriptome nanCOMPLETED
Genetic Variants Associated With Adolescent Suicide Attempts nanCOMPLETED
New Imaging Biomarkers for Muscular Diseases - Multispectral Optoacoustic Imaging in Spinal Muscular Atrophy nanCOMPLETED
Circulating Cell-free DNA-based Epigenetic Biomarker mSEPT9 for Hepatocellular Carcinoma Detection in Cirrhosis nanCOMPLETED
The Effect of Aerobic Exercise Training in Patients With Type III Spinal Muscular Atrophy nanUNKNOWN
Mechanisms of Cell Death in Spinal Muscular Atrophy nanCOMPLETED
Newborn Screening for Spinal Muscular Atrophy (SMA) - a Proof of Principle Study Using Anonymised Blood Spots. nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a SPIN2B binder may also engage these)

ProteinNameSimilarity
Q5RA80 1.000 Q5RA80 →
Q99865 1.000 Q99865 →
Q90WG2 0.995 Q90WG2 →
Q61142 0.995 Q61142 →
SPIN1 Spindlin-1 0.995 landscape →
Q5R997 0.995 Q5R997 →
Q4V8J7 0.993 Q4V8J7 →
SPIN3 Spindlin-3 0.991 landscape →
Q5RAW7 0.991 Q5RAW7 →
Q90WG1 0.990 Q90WG1 →
Q6NVE3 0.975 Q6NVE3 →
Q2KI39 0.960 Q2KI39 →
A7X672 0.938 A7X672 →
Q80U70 0.936 Q80U70 →
Q8L5Y9 0.933 Q8L5Y9 →
SPIN4 Spindlin-4 0.932 landscape →
SUZ12 Polycomb protein SUZ12 0.931 landscape →
Q0J035 0.931 Q0J035 →
Q9SUG3 0.931 Q9SUG3 →
Q8VE62 0.931 Q8VE62 →
ACACA Acetyl-CoA carboxylase 1 0.930 landscape →
D2XV59 0.928 D2XV59 →
P37285 0.928 P37285 →
P11497 0.928 P11497 →
Q28559 0.928 Q28559 →
Q5SWU9 0.928 Q5SWU9 →
P57060 0.928 P57060 →
A3KN28 0.928 A3KN28 →
B8AR41 0.927 B8AR41 →
Q9TTS3 0.927 Q9TTS3 →